Cargando…
The Language of Biosimilars: Clarification, Definitions, and Regulatory Aspects
Biologic therapies have revolutionized treatment of a number of diseases. Patents and exclusivity for a number of biologics are expiring. This has created the opportunity for the development and approval of biosimilars. Biosimilars are biologic products developed using a step-wise approach to result...
Autores principales: | Declerck, Paul, Danesi, Romano, Petersel, Danielle, Jacobs, Ira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5375962/ https://www.ncbi.nlm.nih.gov/pubmed/28258517 http://dx.doi.org/10.1007/s40265-017-0717-1 |
Ejemplares similares
-
Biosimilar Drugs for Psoriasis: Principles, Present, and Near Future
por: Carrascosa, Jose-Manuel, et al.
Publicado: (2018) -
Biosimilars for the Treatment of Chronic Inflammatory Diseases: A Systematic Review of Published Evidence
por: Jacobs, Ira, et al.
Publicado: (2016) -
Monoclonal Antibody and Fusion Protein Biosimilars Across Therapeutic Areas: A Systematic Review of Published Evidence
por: Jacobs, Ira, et al.
Publicado: (2016) -
Regulatory considerations in oncologic biosimilar drug development
por: Macdonald, Judith C, et al.
Publicado: (2015) -
Silent Atrial Fibrillation: Definition, Clarification, and Unanswered Issues
por: Kennedy, Harold L.
Publicado: (2015)